3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Skin Neoplasms
1
Multiple Sclerosis, Relapsing-Remitting
1
Multiple Sclerosis
1
Melanoma
1
Carcinoma, Basal Cell
1
Interventions
HhAntag691
18
Imiquimod
10
sonidegib
8
Photochemotherapy
7
1-phenyl-3,3-dimethyltriazene
6
methyl 5-aminolevulinate
4
Surgical Procedures, Operative
4
Biopsy
4
Aminolevulinic Acid
4
cemiplimab
3
Mohs Surgery
3
Microscopy, Confocal
3
Itraconazole
3
IPI-926
3
3-ingenyl angelate
3
tazarotene
2
Microarray Analysis
2
Laser Therapy
2
Gene Expression Profiling
2
Eflornithine
2
Drug Evaluation
2
Acitretin
2
tozuleristide
1
teriflunomide
1
talimogene laherparepvec
1
silmitasertib
1
remetinostat
1
pembrolizumab
1
gusacitinib
1
green tea extract polyphenone E
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Carcinoma, Basal Cell
×
teriflunomide
×
Clear all
NCT06705608
2024-11-26
MS; FTY720
University of British Columbia
Completed
4,000 enrolled